Page last updated: 2024-08-23

acetylgalactosamine and B16 Melanoma

acetylgalactosamine has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L; Jondal, M; Olofsson, S; Sundbäck, J1
Antolíková, M; Bezouska, K; Bílý, J; Hofbauerová, K; Ivanová, L; Kavan, D; Kovalová, A; Kren, V; Kubícková, M; Kubínková, Z; Ledvina, M; Libigerová, M; Mrázek, H; Pompach, P; Rozbeský, D; Saman, D; Sklenár, V; Vanek, O; Zídek, L; Zyka, D1

Other Studies

2 other study(ies) available for acetylgalactosamine and B16 Melanoma

ArticleYear
Interference with O-glycosylation in RMA lymphoma cells leads to a reduced in vivo growth of the tumor.
    International journal of cancer, 2006, Sep-15, Volume: 119, Issue:6

    Topics: Acetylgalactosamine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzyl Compounds; Cell Survival; Enzyme Inhibitors; Glucosylceramidase; Glycosylation; Humans; Indolizines; Killer Cells, Natural; Lymphoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured

2006
Synthetic N-acetyl-D-glucosamine based fully branched tetrasaccharide, a mimetic of the endogenous ligand for CD69, activates CD69+ killer lymphocytes upon dimerization via a hydrophilic flexible linker.
    Journal of medicinal chemistry, 2010, May-27, Volume: 53, Issue:10

    Topics: Acetylglucosamine; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Carbohydrate Sequence; Cell Line, Tumor; Dimerization; Drug Screening Assays, Antitumor; Female; Humans; Immunologic Factors; In Vitro Techniques; Killer Cells, Natural; Lectins, C-Type; Ligands; Lymphocyte Activation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Mimicry; Molecular Sequence Data; NK Cell Lectin-Like Receptor Subfamily B; Oligosaccharides; Rats; Recombinant Proteins

2010